Atrial fibrillation (AF) catheter ablation is a well-known treatment option for patients with drug refractory AF. The increasing number of electrophysiology laboratories able to perform this procedure will create an economic impact in the coming years, which each cardiac electrophysiologist will have to face with. Identification of predictors of recurrence of AF after catheter ablation is therefore of primary importance to reduce health costs and improve long-term results of this intervention. The aim of this review is to give a brief overview on published literature on the topic and henceforth to increase the awareness of cardiac electrophysiophysiologists on the importance of selecting of the right candidates for this intervention.
Credits: Gianluca Epicoco MD; Antonio Sorgente MD, PhD